In fact, a review editorial was published last week in JAMA Internal Medicine in which the authors were even more hard line and found no reason whatsoever for prescribing the two newest brand only statins. I suppose if the copay is the same to you regardless of which statin was prescribed, you might not care. But remember that any expenses are traced back to corporate headquarters such that your insurance rate may be going up next year. So perhaps it's not really free after all.
This site complies with the HONcode standard for trustworthy health information: